Approved Ligands

Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-Raf V600E with IC50 of 31 nM.A novel and potent inhibitor of B-RAFV600E with IC50 of 31 nM.

Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-Raf V600E with IC50 of 31 nM.A novel and potent inhibitor of B-RAFV600E with IC50 of 31 nM.

Verapamil.

Verapamil.

Verapamil.

GABA-T inhibitor.

Vilanterol (GW642444: GW 642444X) is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma.

Vilanterol (GW642444: GW 642444X) is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma.

Vilanterol (GW642444: GW 642444X) is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma.

Vilanterol (GW642444: GW 642444X) is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma.

Vilazodone is an inhibitor of ST (serotonin transporter and uptake) (IC50 = 0.5 nM) and SR-1A activator (partial agonist) (IC50 = 0.2 nM: IA = ~60-70%).An inhibitor of ST and activator of SR-1A.

Vilazodone is an inhibitor of ST (serotonin transporter and uptake) (IC50 = 0.5 nM) and SR-1A activator (partial agonist) (IC50 = 0.2 nM: IA = ~60-70%).An inhibitor of ST and activator of SR-1A.